Skip to main content
Equibles

Simon Scholz

Analyst

First Berlin Equity Research

Equibles does not estimate personal net worth.

About Simon Scholz

Simon Scholz is recorded as Analyst at First Berlin Equity Research. Simon Scholz has spoken on 2 earnings calls across 2 companies, most recently for VALNEVA on May 13, 2026. Those appearances were for VALNEVA and Valneva SE (VALN). The companies whose calls Simon Scholz spoke on are classified in the Healthcare sector.

Simon Scholz on recent calls

“You wrote in the 2025-20F that you'd received a letter from the FDA preventing you from using the Almeida facility to produce Xero for distribution in the U.S. I was just wondering if you could outline current measures to mitigate that and also give us some idea as to whether this will impact sales of Xero or your…”
Analyst — First Berlin Equity Research, Q1 2026 Financial Results ·
“You wrote in the 2025-20F that you'd received a letter from the FDA preventing you from using the Almeida facility to produce Xero for distribution in the U.S. I was just wondering if you could outline current measures to mitigate that and also give us some idea as to whether this will impact sales of Xero or your…”
Analyst — First Berlin Equity Research, Earnings conference call (announced in 6-K) ·

Affiliation history

  • First Berlin Equity Research

    Analyst

    Transcript header (unverified)

    Current

Company network

VALNEVA

Biotechnology · Healthcare

1 appearance Latest appearance 2026-05-13

Recent activity